Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4158029

N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)N(CCN1CCC(c2ccccc2)C1)C(=O)CNC(=O)c1ccccc1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
CCR2 P41597 13/20 0.35
DRD2 P14416 2/20 0.34
HTR1A P08908 1/20 0.34
DRD1 P21728 1/20 0.34
DRD4 P21917 1/20 0.34
DRD5 P21918 1/20 0.34
DRD3 P35462 1/20 0.34
USP5 P45974 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4158032 0.86 ALDH1A1 (0.36) ALDH1A1LMNAGAAKMT2ACCR2
Trifluoroacetic Acid SCHEMBL4156616 0.80 CHRM4 (0.41) LMNAKMT2ACCR2DRD2DRD4
Trifluoroacetic Acid SCHEMBL4162610 0.73 HDAC1 (0.34) KMT2ADRD2DRD3
Trifluoroacetic Acid SCHEMBL3502968 0.73 POLQ (0.36) ALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL4156617 0.72 ACHE (0.41) LMNAKMT2ACCR2DRD2DRD4
Trifluoroacetic Acid SCHEMBL4165154 0.72 CCR5 (0.38) ALDH1A1LMNAGAAKMT2ACCR2
Trifluoroacetic Acid SCHEMBL4165152 0.71 ALDH1A1 (0.39) ALDH1A1LMNAGAAKMT2ACCR2
Trifluoroacetic Acid SCHEMBL4618890 0.69 ALDH1A1 (0.35) ALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL4171681 0.69 CCR2 (0.38) CCR2
Trifluoroacetic Acid SCHEMBL4166952 0.68 CCR2 (0.40) ALDH1A1LMNAGAAKMT2ACCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 ALDH1A1 320/4885LMNA 3720/4885GAA 503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.